Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trickle down baby!!!!!!!!GO DGAZ!!!!!!!!!!!!!!!
I say it trickles down over night!!!!GO DGAZ
Thank you!!!! Hopefully its good for DGAZ!!!
Can anyone tell me how the injection turned out today? Thanks in advance! GO DGAZ!!!!
Just hit ya with #231!!
Thank you cha-ching!!! I like your post. You seem to tell it like it is one way or the other! GO DGAZ!!!!
Is that good for DGAZ or bad because injection will be smaller?
Can anyone tell me if I will be able to get out of this anytime soon without losing my ass completely? I bought a nice chunk of DGAZ @6.10 and then another chunk averaging down @4.30. My new average with over 4k in shares is 5.33.
I have a lot in this and would like to get out without losing all.
One good thing I noticed is they never reverse split yet. yet!!!
So True!!!!!!!GO MHYS$$$$$$$$$$$$$
I see if we don't see any action taken for today's date within the
next week than it looks good for whatever settlement to go through by the end of the month. Right?
My question to you is am I screwd? I bought dgaz @5.85. Are you saying it wont go back up? Please advise.
Thanks in Advance!
Yes sir!!! Also ask keeps on dropping!!! Cant wait till court chit is all wrapped up and this puppy can run! Go MHYS$$$$
Thanks Tony I was just going to say that but with less detail! Your response is much better than mine would've been :)
MHYS$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
I didn't see it under 100mil. This is the lowest I've seen in over a year!
Only 148mil!!! Wow!! They are ready to let her run!!!!!!
I agree with you and wish he would but I don't think Dan budges at all until the court crap is all done! Good thing the end is coming one way or another. I do believe we are way under value because I do believe Dan is holding back on his positive cashflow from these movies. I agree with many of you here that the Kramers wouldn't fight so hard in court over this if there wasn't positive numbers to talk about. We soon shall see!!!! The end of the bulls##t is near!!!!
GO MHYS$$$$$ Dan bring us the Green!!!!!!
Only 180mil on the Ask!!! Hmmmmmmm
GO MHYS$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
I think just getting current and updating share holders takes us over .002
:)
My opinion!
Only if Dan G. does a share buyback or a share reduction. Current
authorized which scares everyone is 30 billion. Get that number to 15 or under, get current, and show some positive numbers he is hiding and this could go .005 and into pennies with no problem! Buy the way welcome aboard! GO MHYS!!!!!
We all know he added the extra 15 billion shares just to keep Kramers or anyone else from taking over our company!
If this is hitting theatres world wide we are golden!!!!!At the least 30mil. GO MHYS!! I love seeing our logo on everthing!!!!
Is this going to theatres or just video ondemand, redbox, and video sales?
Okay I like it! I have 140 mil shares but I got sick of waiting for a pop so I had a small 60 mil chunk on the ask. I know all is getting ready to happen within months so give me 10 minutes and
I will drop the ask by 60. time is now 11:48
GO MHYS
Have a link to trailer? Would like to see. GO MHYS!!!
.002---YOU MISSED A ZERO! LOL
IMO They know there is real profit and they want a share of the action. They are fighting in everyway to get Dan to open up about everything and get the stock current for them to get a piece of the action. You will see this all unfold sooner or later. I don't care about the ney sayers. This stock will run when Dan and Kramers kiss and makeup!
If its Kramers they aren't done yet. They have to chip away till they do 500 million shares without causing the price to go up.
Cool thanks!!
Thank you! I ve been trading for many years but I was always afraid to do the orders wrong so I never tried to short a stock till the last few weeks. Its amazing the you can just google how to short a stock. This stocks seems to be perfect to short.
Is it good to short it while it is so low right now?
Would it be good to short a big portion at these levels and let the RS happen?
A buddy of mine at work thinks so but I thought it might be better to short it after an RS.
THOUGHTS?
Can TVIX be shorted because all I ever seen it do is go down. I never tried it but can someone answer this please. Thanks in advance!
I agree with sir!!! Gold on the rise!!!!!!!!!!!!!!!!!!!!
Yeah im shocked to see ask so low!!!!GO BABY GO!!!
MHYS$$$$$$
I agree this thing pops 40/50 cent higher tomorrow!! Way to much negative happening in the world to keep having positive days in the market! The Dow goes red tomorrow!!!!!GO TVIX!!!!!!
Excellent work buddy!!!!! I sure hope we can finally celebrate with a little run in the near future! Us longs have been here for a long time now. Only one good thing for us is we now pay tax on long term investment instead of the high bracket for short!
GO MHYS!!!!!!!!!!!!!!!!!!
It works for me too! GO WEEDHIRE!!!!!!!!!!!!!!!!!!!$$$$$$$$$$$
You tell him buddy!!!!! I have a lot of shares and happy I have them!!!!!!Go MHYS!!!!
Great job Tonyo524!!!! Love all your input!! GO MHYS!!!!
Not working for me! :(
NEWS!
CLRB Trade
News 4.07 0
Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor Conference
May 24, 2016 08:30:00 (ET)
Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor Conference
MADISON, Wis., May 24, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the 5(th) Annual SeeThru Equity Microcap Investor Conference on Tuesday, May 31, 2016 at 11:00 AM ET. The conference is being held at Convene, which is located at 730 Third Avenue in New York City.
"We will continue to actively engage and educate the investment community on the unique science and clinical potential of our Phospholipid Drug Conjugate (PDC) delivery platform and associated product pipeline," said Mr. Caruso. "The SeeThru Equity Microcap Investor Conference provides a meaningful opportunity to expand awareness of our novel technology and provide a company performance update."
Following the presentation, a link will be posted to the company's website and include the presentation and accompanying audio.
About Cellectar Biosciences, Inc.
Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar's PDC Delivery Platform is based on the company's proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar's PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The company's lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. CLR 131 is currently being evaluated under an orphan drug designated Phase 1 study in patients with relapsed or refractory multiple myeloma. The company is also developing PDCs for targeted delivery of chemotherapeutics such as paclitaxel (CLR 1602-PTX), a preclinical stage product candidate, and plans to expand its PDC chemotherapeutic pipeline through both in-house and collaborative R&D efforts. For additional information please visit www.cellectarbiosciences.com.
This news release contains forward-looking statements. You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates. These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to raise additional capital, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement. A complete description of risks and uncertainties related to our business is contained in our periodic reports filed with the Securities and Exchange Commission including our Form 10-K for the year ended December 31, 2015. These forward-looking statements are made only as of the date hereof, and we disclaim any obligation to update any such forward-looking statements.
INVESTOR AND MEDIA CONTACT:
Jules Abraham
JQA Partners
917-885-7378
jabraham@jqapartners.com
(MORE TO FOLLOW) Dow Jones Newswires
May 24, 2016 08:30 ET (12:30 GMT)
Yeah maybe! Premarket isn't to nice. GO CLRB!!!!